A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive

INTRODUCTION: Buprenorphine is a partial μ-opioid receptor agonist that, unlike full μ-opioid receptor agonists, has been shown to have a ceiling effect on respiratory depression. Buprenorphine buccal film (BBF) is approved by the US Food and Drug Administration for use in patients with chronic pain...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Lynn R., Hansen, Erik, Cater, Jacqueline, Smith, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547962/
https://www.ncbi.nlm.nih.gov/pubmed/32978722
http://dx.doi.org/10.1007/s12325-020-01481-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547962/
https://www.ncbi.nlm.nih.gov/pubmed/32978722
http://dx.doi.org/10.1007/s12325-020-01481-0

Ejemplares similares